Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis

Journal of Investigative Dermatology

Volumn 106, Issue 3, 1996, Pages 397-403

  Wood, Ladonna C ^a   Elias, Peter M ^b   Calhoun, Cornelia ^b   Tsai, Janice C ^b   Grunfeld, Carl ^b   Feingold, Kenneth R ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cytokines; Essential fatty acid deficiency; Immunolocalization; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1ALPHA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESSENTIAL FATTY ACID DEFICIENCY; GENE EXPRESSION; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION;

EID: 0029883952     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12343392     Document Type: Article

References (30)

1. Ansel JC, Luger TA, Roop DR, Mountz J: The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol 140:2274-2278, 1988
2. Camp R, Fincham N, Ross J, Bird C, Gearing A: Potent inflammatory properties in human skin of interleukin 1 alpha-like material isolated from normal skin. J Invest Dermatol 94:735-741, 1990
3. Didierjean L, Salomon D, Merot Y, Siegenthaler G, Shaw A, Dayer J-M, Saurat J-H: Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis. J Invest Dermatol 92:809-816, 1989
4. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991
5. Elias PM, Brown BE: The mammalian cutaneous permeability barrier: defective barrier function in essential fatty acid deficiency correlates with abnormal intercellular lipid disposition. Lab Invest 39:574-583, 1978
6. Gahring LC, Buckley A, Daynes RA: Presence of epidermal-derived thymocyte activating factor/interleukin-1 in normal human stratum corneum. J Clin Invest 76:1585-1591, 1986
7. Grubauer G, Feingold KR, Elias PM: The relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res 28:746-752, 1987
8. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 30:323-333, 1989
9. Haas J, Lipkow T, Mohamadzadeh M, Kolde G, Knop J: Inflammatory cytokines in murine keratinocytes upon in vivo stimulation with contact sensitizers and tolerizing analogues. Exp Dermatol 1:76-83, 1992
10. Hauser C, Saurat J-H, Schmitt JA, Jaunin P, Dayer JH: Interleukin-1 is present in normal human epidermis. J Immunol 136:3317-3322, 1986
11. Hogquist KA, Neu MA, Unanue ER, Chaplin DD: Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A 88:8485-8489, 1991
12. Konnikov N, Pincus SH, Dinarello CA: Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. J Invest Dermatol 92:235-239, 1989
13. Kupper TS, Ballard D, Chua AO, McGuire J, Flood P, Horowitz M, Langdon R, Gubler U: Human keratinocytes contain mRNA indistinguishable from monocyte IL-1 alpha and beta mRNA. J Exp Med 69:2095-2100, 1986
14. Kupper TS: Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86:1783-1789, 1990
15. Luger TA, Schwartz T: Evidence for an epidermal cytokine network. J Invest Dermatol 95:100S-104S, 1990
16. Menton DN: The effects of essential fatty acid deficiency on the skin of the mouse. Am J Anat 122:337-355, 1968
17. Murphy GM, Dowd PM, Hudspith BN, Brostoff J, Greaves MW: Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photodermatology 6:268-274, 1989
18. Ness GC, Sample CE, Smith M, Pendleton LC, Eichler DC: Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochem J 233: 167-172, 1986
19. Nickoloff BJ, Naidu Y: Perturbation of epidermal harrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-546, 1994
20. Oberyszyn TM, Sabourin CL, Bijur GN, Oberyszyn AS, Boros LG, Robertson FM: Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Mol Carcinog 7:238-248, 1993
21. Oxholm A, Oxholm P, Staberg B, Bendtzen K: Immunohistological detection of interleukin-1-like molecules and tumor necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol 118:369-376, 1988
22. Proksch E, Feingold KR, Man MQ, Elias PM: Barrier function regulates epidermal DNA synthesis. J Clin Invest 87:1668-1673, 1991
23. Proksch E, Feingold KR, Elias PM: Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. J Invest Dermatol 99:216-220, 1992
24. Reitamo S, Anttila HS, Didierjean L, Saurat JH: Immunohistochemical identification of interleukin I alpha and beta in human eccrine sweat-gland apparatus. Br J Dermatol 122:315-323, 1990
25. Romero LI, Ikejima T, Pincus SH: In situ localization of interleukin-1 in normal and psoriatic skin. J Invest Dermatol 93:518-522, 1989
26. Tsai JC, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM: Permeability harrier disruption alters the localization and expression of TNF alpha protein in the epidermis. Arch Dermatol Res 286:242-248, 1994
27. Wilmer JL, Burleson FG, Kayama F, Kanno J, Luster MI: Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 102:915-922, 1994
28. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992
29. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C: Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol 3:56-60, 1994a
30. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR: Occlusion lowers cytokine mRNA levels in essential fatty acid deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-838, 1994b